Gilead Sciences Partners With White House For Early Cancer Detection Program“Biden Cancer Moonshot”

2024-05-28 02:03:47

(MENAFN- 3BL) In an effort to advance access to cancer prevention and early detection among U.S. workers, the Biden Cancer Moonsho recently announced a series of actions that organizations are taking to improve access and use of cancer screenings. We're proud to be included on the list for our commitment to help increase screening rates among employees through personalized outreach.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences

MENAFN28052024007202015466ID1108266845

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.